Rifampicin-induced Pancytopenia in Pulmonary Tuberculosis Patient: A Rare Presentation
Tuberculosis (TB) is prevalent throughout the world and is a major public health problem in most developing countries. In India, standardised and Directly Observed Treatment (DOT) under National Tuberculosis Elimination Programme (NTEP) is being recommended currently for drug-sensitive pulmonary TB....
Main Authors: | Yashika Bansal, Nitin Tangri |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2024-03-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://www.jcdr.net/articles/PDF/19102/67726_CE[Ra1]_F(IS)_PF1(KB_SS_OM)_PF_NC(KM)_Ref_Pat(OM)_PN(KM).pdf |
Similar Items
-
Treatment outcomes and influencing factors on patients with Pulmonary Tuberculosis: a retrospective study
by: Jamshid Ayatollahi, et al.
Published: (2021-02-01) -
Treatment outcomes associated with multidrug-resistant tuberculosis
by: Nitin Gupta, et al.
Published: (2018-01-01) -
Isoniazid Induced Lupus Presenting as Oral Mucosal Ulcers with Pancytopenia
by: RIA SHAH, et al.
Published: (2016-10-01) -
A Case of Immune Thrombocytopenic Purpura Secondary to Pulmonary Tuberculosis
by: Sameer Panda, et al.
Published: (2016-10-01) -
Croup syndrome and primary infection with mycobacterium tuberculosis in children
by: L. I. Mozzhukhina, et al.
Published: (2019-02-01)